Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)

Background Transthyretin amyloidosis (ATTR) is a heterogeneous disorder with multiorgan involvement and a genetic or nongenetic basis. Objectives The goal of this study was to describe ATTR in the United States by using data from the THAOS (Transthyretin Amyloidosis Outcomes Survey) registry. Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Maurer, Mathew S. (Author) , Kristen, Arnt (Author)
Format: Article (Journal)
Language:English
Published: 4 July 2016
In: Journal of the American College of Cardiology
Year: 2016, Volume: 68, Issue: 2, Pages: 161-172
ISSN:1558-3597
DOI:10.1016/j.jacc.2016.03.596
Online Access:Verlag, Volltext: http://dx.doi.org/10.1016/j.jacc.2016.03.596
Verlag, Volltext: http://www.sciencedirect.com/science/article/pii/S0735109716330108
Get full text
Author Notes:Mathew S. Maurer, Mazen Hanna, Martha Grogan, Angela Dispenzieri, Ronald Witteles, Brian Drachman, Daniel P. Judge, Daniel J. Lenihan, Stephen S. Gottlieb, Sanjiv J. Shah, D. Eric Steidley, Hector Ventura, Srinivas Murali, Marc A. Silver, Daniel Jacoby, Savitri Fedson, Scott L. Hummel, Arnt V. Kristen, Thibaud Damy, Violaine Planté-Bordeneuve, Teresa Coelho, Rajiv Mundayat, Ole B. Suhr, Márcia Waddington Cruz, Claudio Rapezzi, on behalf of the THAOS Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1586217178
003 DE-627
005 20240316100550.0
007 cr uuu---uuuuu
008 190115s2016 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jacc.2016.03.596  |2 doi 
035 |a (DE-627)1586217178 
035 |a (DE-576)516217178 
035 |a (DE-599)BSZ516217178 
035 |a (OCoLC)1341033490 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Maurer, Mathew S.  |e VerfasserIn  |0 (DE-588)1175452637  |0 (DE-627)1046420038  |0 (DE-576)516216341  |4 aut 
245 1 0 |a Genotype and phenotype of transthyretin cardiac amyloidosis  |b THAOS (Transthyretin Amyloid Outcome Survey)  |c Mathew S. Maurer, Mazen Hanna, Martha Grogan, Angela Dispenzieri, Ronald Witteles, Brian Drachman, Daniel P. Judge, Daniel J. Lenihan, Stephen S. Gottlieb, Sanjiv J. Shah, D. Eric Steidley, Hector Ventura, Srinivas Murali, Marc A. Silver, Daniel Jacoby, Savitri Fedson, Scott L. Hummel, Arnt V. Kristen, Thibaud Damy, Violaine Planté-Bordeneuve, Teresa Coelho, Rajiv Mundayat, Ole B. Suhr, Márcia Waddington Cruz, Claudio Rapezzi, on behalf of the THAOS Investigators 
264 1 |c 4 July 2016 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.01.2019 
520 |a Background Transthyretin amyloidosis (ATTR) is a heterogeneous disorder with multiorgan involvement and a genetic or nongenetic basis. Objectives The goal of this study was to describe ATTR in the United States by using data from the THAOS (Transthyretin Amyloidosis Outcomes Survey) registry. Methods Demographic, clinical, and genetic features of patients enrolled in the THAOS registry in the United States (n = 390) were compared with data from patients from other regions of the world (ROW) (n = 2,140). The focus was on the phenotypic expression and survival in the majority of U.S. subjects with valine-to-isoleucine substitution at position 122 (Val122Ile) (n = 91) and wild-type ATTR (n = 189). Results U.S. subjects are older (70 vs. 46 years), more often male (85.4% vs. 50.6%), and more often of African descent (25.4% vs. 0.5%) than the ROW. A significantly higher percentage of U.S. patients with ATTR amyloid seen at cardiology sites had wild-type disease than the ROW (50.5% vs. 26.2%). In the United States, 34 different mutations (n = 201) have been reported, with the most common being Val122Ile (n = 91; 45.3%) and Thr60Ala (n = 41; 20.4%). Overall, 91 (85%) of 107 patients with Val122Ile were from the United States, where Val122Ile subjects were younger and more often female and black than patients with wild-type disease, and had similar cardiac phenotype but a greater burden of neurologic symptoms (pain, numbness, tingling, and walking disability) and worse quality of life. Advancing age and lower mean arterial pressure, but not the presence of a transthyretin mutation, were independently associated with higher mortality from a multivariate analysis of survival. Conclusions In the THAOS registry, ATTR in the United States is overwhelmingly a disorder of older adult male subjects with a cardiac-predominant phenotype. Val122Ile is the most common transthyretin mutation, and neurologic phenotypic expression differs between wild-type disease and Val122Ile, but survival from enrollment in THAOS does not. (Transthyretin-Associated Amyloidoses Outcome Survey [THAOS]; NCT00628745) 
650 4 |a aging 
650 4 |a amyloid 
650 4 |a transthyretin 
700 1 |a Kristen, Arnt  |d 1974-  |e VerfasserIn  |0 (DE-588)123480965  |0 (DE-627)706314530  |0 (DE-576)293726876  |4 aut 
773 0 8 |i Enthalten in  |a American College of Cardiology  |t Journal of the American College of Cardiology  |d New York, NY : Elsevier, 1983  |g 68(2016), 2, Seite 161-172  |h Online-Ressource  |w (DE-627)266884717  |w (DE-600)1468327-1  |w (DE-576)099603837  |x 1558-3597  |7 nnas 
773 1 8 |g volume:68  |g year:2016  |g number:2  |g pages:161-172  |g extent:12  |a Genotype and phenotype of transthyretin cardiac amyloidosis THAOS (Transthyretin Amyloid Outcome Survey) 
856 4 0 |u http://dx.doi.org/10.1016/j.jacc.2016.03.596  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0735109716330108  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190115 
993 |a Article 
994 |a 2016 
998 |g 123480965  |a Kristen, Arnt  |m 123480965:Kristen, Arnt  |d 910000  |e 910000PK123480965  |k 0/910000/  |p 18 
999 |a KXP-PPN1586217178  |e 3045047831 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Genotype and phenotype of transthyretin cardiac amyloidosis","subtitle":"THAOS (Transthyretin Amyloid Outcome Survey)","title_sort":"Genotype and phenotype of transthyretin cardiac amyloidosis"}],"note":["Gesehen am 15.01.2019"],"language":["eng"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"New York, NY ; New York, NY","dateIssuedDisp":"1983-","dateIssuedKey":"1983","publisher":"Elsevier ; American College of Cardiology"}],"pubHistory":["1.1983 -"],"disp":"American College of CardiologyJournal of the American College of Cardiology","part":{"issue":"2","pages":"161-172","extent":"12","volume":"68","text":"68(2016), 2, Seite 161-172","year":"2016"},"recId":"266884717","id":{"zdb":["1468327-1"],"issn":["1558-3597"],"eki":["266884717"]},"corporate":[{"role":"aut","display":"American College of Cardiology"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 13.11.25","Ungezählte Beil.: Supplement"],"titleAlt":[{"title":"JACC"}],"title":[{"title_sort":"Journal of the American College of Cardiology","title":"Journal of the American College of Cardiology","subtitle":"JACC"}]}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1586217178","person":[{"display":"Maurer, Mathew S.","given":"Mathew S.","role":"aut","family":"Maurer"},{"family":"Kristen","role":"aut","given":"Arnt","display":"Kristen, Arnt"}],"name":{"displayForm":["Mathew S. Maurer, Mazen Hanna, Martha Grogan, Angela Dispenzieri, Ronald Witteles, Brian Drachman, Daniel P. Judge, Daniel J. Lenihan, Stephen S. Gottlieb, Sanjiv J. Shah, D. Eric Steidley, Hector Ventura, Srinivas Murali, Marc A. Silver, Daniel Jacoby, Savitri Fedson, Scott L. Hummel, Arnt V. Kristen, Thibaud Damy, Violaine Planté-Bordeneuve, Teresa Coelho, Rajiv Mundayat, Ole B. Suhr, Márcia Waddington Cruz, Claudio Rapezzi, on behalf of the THAOS Investigators"]},"id":{"doi":["10.1016/j.jacc.2016.03.596"],"eki":["1586217178"]},"origin":[{"dateIssuedDisp":"4 July 2016","dateIssuedKey":"2016"}],"physDesc":[{"extent":"12 S."}]} 
SRT |a MAURERMATHGENOTYPEAN4201